Affymetrix (Santa Clara, California) Enables Analysis of Challenging Sample Types Through Exclusive Agreement With Genisphere

Published: Nov 16, 2011

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix®, Inc. (NASDAQ:AFFX) announced today that it has entered into an exclusive, worldwide licensing agreement with Genisphere®, LLC, for RNA amplification and labeling technology to address challenging sample types including formalin-fixed, paraffin-embedded (FFPE) samples for GeneChip® Arrays.

Back to news